These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31069281)

  • 21. Electro-thermal therapy: Microsecond duration pulsed electric field tissue ablation with dynamic temperature control algorithms.
    Sano MB; Petrella RA; Kaufman JD; Fesmire CC; Xing L; Gerber D; Fogle CA
    Comput Biol Med; 2020 Jun; 121():103807. PubMed ID: 32568680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A three-dimensional in vitro tumor platform for modeling therapeutic irreversible electroporation.
    Arena CB; Szot CS; Garcia PA; Rylander MN; Davalos RV
    Biophys J; 2012 Nov; 103(9):2033-42. PubMed ID: 23199931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burst and continuous high frequency irreversible electroporation protocols evaluated in a 3D tumor model.
    Sano MB; Fesmire CC; DeWitt MR; Xing L
    Phys Med Biol; 2018 Jul; 63(13):135022. PubMed ID: 29978834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrolytic Effects During Tissue Ablation by Electroporation.
    Rubinsky L; Guenther E; Mikus P; Stehling M; Rubinsky B
    Technol Cancer Res Treat; 2016 Oct; 15(5):NP95-NP103. PubMed ID: 26323571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irreversible electroporation is a thermally mediated ablation modality for pulses on the order of one microsecond.
    Fesmire CC; Petrella RA; Kaufman JD; Topasna N; Sano MB
    Bioelectrochemistry; 2020 Oct; 135():107544. PubMed ID: 32438309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temperature Dependence of High Frequency Irreversible Electroporation Evaluated in a 3D Tumor Model.
    Fesmire CC; Petrella RA; Fogle CA; Gerber DA; Xing L; Sano MB
    Ann Biomed Eng; 2020 Aug; 48(8):2233-2246. PubMed ID: 32409902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Properties of tissue within prostate tumors and treatment planning implications for ablation therapies.
    Beitel-White N; Aycock KN; Manuchehrabadi N; Zhao Y; Imran KM; Coutermarsh-Ott S; Allen IC; Lorenzo MF; Davalos RV
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():1539-1542. PubMed ID: 34891577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irreversible electroporation: implications for prostate ablation.
    Onik G; Mikus P; Rubinsky B
    Technol Cancer Res Treat; 2007 Aug; 6(4):295-300. PubMed ID: 17668936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b).
    Buijs M; van Lienden KP; Wagstaff PG; Scheltema MJ; de Bruin DM; Zondervan PJ; van Delden OM; van Leeuwen TG; de la Rosette JJ; Laguna MP
    JMIR Res Protoc; 2017 Feb; 6(2):e21. PubMed ID: 28209559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI-TRUS fusion for electrode positioning during irreversible electroporation for treatment of prostate cancer.
    Baur ADJ; Collettini F; Enders J; Maxeiner A; Schreiter V; Stephan C; Gebauer B; Hamm B; Fischer T
    Diagn Interv Radiol; 2017; 23(4):321-325. PubMed ID: 28508759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrical conductivity changes during irreversible electroporation treatment of brain cancer.
    Garcia PA; Rossmeisl JH; Davalos RV
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():739-42. PubMed ID: 22254416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishing Irreversible Electroporation Electric Field Potential Threshold in A Suspension In Vitro Model for Cardiac and Neuronal Cells.
    Avazzadeh S; O'Brien B; Coffey K; O'Halloran M; Keane D; Quinlan LR
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Feasibility of Enhancing Susceptibility of Glioblastoma Cells to IRE Using a Calcium Adjuvant.
    Wasson EM; Ivey JW; Verbridge SS; Davalos RV
    Ann Biomed Eng; 2017 Nov; 45(11):2535-2547. PubMed ID: 28849278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First Human Trial of High-Frequency Irreversible Electroporation Therapy for Prostate Cancer.
    Dong S; Wang H; Zhao Y; Sun Y; Yao C
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818789692. PubMed ID: 30045668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients.
    van den Bos W; de Bruin DM; Jurhill RR; Savci-Heijink CD; Muller BG; Varkarakis IM; Skolarikos A; Zondervan PJ; Laguna-Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ
    World J Urol; 2016 May; 34(5):657-64. PubMed ID: 26296371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
    van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
    BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrode activation sequencing employing conductivity changes in irreversible electroporation tissue ablation.
    Sahakian AV; Al-Angari HM; Adeyanju OO
    IEEE Trans Biomed Eng; 2012 Mar; 59(3):604-7. PubMed ID: 22194234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.
    Dunki-Jacobs EM; Philips P; Martin RC
    Br J Surg; 2014 Aug; 101(9):1113-21. PubMed ID: 24961953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Frequency Irreversible Electroporation for Intracranial Meningioma: A Feasibility Study in a Spontaneous Canine Tumor Model.
    Latouche EL; Arena CB; Ivey JW; Garcia PA; Pancotto TE; Pavlisko N; Verbridge SS; Davalos RV; Rossmeisl JH
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818785285. PubMed ID: 30071778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lethal Electric Field Thresholds for Cerebral Cells With Irreversible Electroporation and H-FIRE Protocols: An In Vitro Three-Dimensional Cell Model Study.
    Shu T; Ding L; Fang Z; Yu S; Chen L; Moser MAJ; Zhang W; Qin Z; Zhang B
    J Biomech Eng; 2022 Oct; 144(10):. PubMed ID: 35445240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.